drugset / Trial / NCT07741877

A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Soft Tissue Sarcoma

NCT07741877 ↗

Phase 2 Recruiting 80 enrolled Iovance Biotherapeutics, Inc.
NaSingle-groupOpen-labelTreatment

Summary

A study of lifileucel (tumor-infiltrating lymphocytes) in adults with advanced soft tissue sarcoma ('SARATOGA')

Timeline

Start
2026-10-02
Primary completion
2033-09-01
Completion
2034-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Tumor Infiltrating Lymphocytes Cell therapy — —